News + Resources
Helping Patients on a Global Scale: How the Mission Behind Treating Sickle Cell Disease Relied on Two Companies Joining Forces
For most Americans, the term “mergers and acquisitions” (M&A) may not resonate beyond two companies coming together. In the case of biopharmaceutical M&A, the concept and the impact often mean a transformational medicine can make its way to patients far faster...
Pro-Innovation Mergers & Acquisitions: Maintaining America’s Leadership in Biopharmaceutical Breakthroughs
Thousands of U.S. life sciences companies race every day to find better treatments and cures for a wide range of conditions and diseases. Within this diverse and dynamic life sciences ecosystem – made up of early-stage companies, large-scale entities, research...
The Pro-Competition Policies Driving Life Science Innovation
America has a long history of enacting sound, bipartisan policies that have created powerful incentives for life sciences innovators to invest in the costly, extensive research and development (R&D) process behind groundbreaking treatments and cures. These...